- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-24-mer
- Ligands
- 48 x FE2: FE (II) ION(Non-covalent)
- 78 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 5 residues within 4Å:- Chain A: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.4: 2 residues within 4Å:- Chain A: S.144, N.148
Ligand excluded by PLIPSO4.5: 5 residues within 4Å:- Chain A: K.114
- Chain I: K.114
- Chain Q: K.114
- Ligands: SO4.51, SO4.97
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: P.161, S.162, S.163
Ligand excluded by PLIPSO4.10: 6 residues within 4Å:- Chain B: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.7
Ligand excluded by PLIPSO4.11: 3 residues within 4Å:- Chain B: S.144, K.147, N.148
Ligand excluded by PLIPSO4.12: 3 residues within 4Å:- Chain B: P.161, S.162, S.163
Ligand excluded by PLIPSO4.13: 2 residues within 4Å:- Chain C: K.114
- Chain W: K.114
Ligand excluded by PLIPSO4.16: 3 residues within 4Å:- Chain C: S.144, K.147, N.148
Ligand excluded by PLIPSO4.17: 3 residues within 4Å:- Chain C: P.161, S.162, S.163
Ligand excluded by PLIPSO4.21: 5 residues within 4Å:- Chain D: K.50, S.163, T.164, G.165
- Ligands: FEC.18
Ligand excluded by PLIPSO4.22: 2 residues within 4Å:- Chain D: N.4, R.5
Ligand excluded by PLIPSO4.23: 3 residues within 4Å:- Chain D: P.161, S.162, S.163
Ligand excluded by PLIPSO4.26: 4 residues within 4Å:- Chain E: K.50, S.163, T.164, G.165
Ligand excluded by PLIPSO4.27: 3 residues within 4Å:- Chain E: S.144, K.147, N.148
Ligand excluded by PLIPSO4.28: 3 residues within 4Å:- Chain E: P.161, S.162, S.163
Ligand excluded by PLIPSO4.31: 6 residues within 4Å:- Chain F: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.35
Ligand excluded by PLIPSO4.32: 2 residues within 4Å:- Chain F: N.4, R.5
Ligand excluded by PLIPSO4.33: 5 residues within 4Å:- Chain F: K.114
- Chain N: K.114
- Chain V: K.114
- Ligands: SO4.79, SO4.125
Ligand excluded by PLIPSO4.34: 3 residues within 4Å:- Chain F: P.161, S.162, S.163
Ligand excluded by PLIPSO4.38: 2 residues within 4Å:- Chain G: S.144, N.148
Ligand excluded by PLIPSO4.39: 3 residues within 4Å:- Chain G: P.161, S.162, S.163
Ligand excluded by PLIPSO4.40: 3 residues within 4Å:- Chain D: K.114
- Chain E: K.114
- Chain H: K.114
Ligand excluded by PLIPSO4.43: 5 residues within 4Å:- Chain H: K.50, S.163, T.164, G.165
- Ligands: FEC.46
Ligand excluded by PLIPSO4.44: 3 residues within 4Å:- Chain H: S.144, K.147, N.148
Ligand excluded by PLIPSO4.45: 3 residues within 4Å:- Chain H: P.161, S.162, S.163
Ligand excluded by PLIPSO4.49: 5 residues within 4Å:- Chain I: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.50: 2 residues within 4Å:- Chain I: S.144, N.148
Ligand excluded by PLIPSO4.51: 5 residues within 4Å:- Chain A: K.114
- Chain I: K.114
- Chain Q: K.114
- Ligands: SO4.5, SO4.97
Ligand excluded by PLIPSO4.52: 3 residues within 4Å:- Chain I: P.161, S.162, S.163
Ligand excluded by PLIPSO4.56: 6 residues within 4Å:- Chain J: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.53
Ligand excluded by PLIPSO4.57: 3 residues within 4Å:- Chain J: S.144, K.147, N.148
Ligand excluded by PLIPSO4.58: 3 residues within 4Å:- Chain J: P.161, S.162, S.163
Ligand excluded by PLIPSO4.59: 2 residues within 4Å:- Chain G: K.114
- Chain K: K.114
Ligand excluded by PLIPSO4.62: 3 residues within 4Å:- Chain K: S.144, K.147, N.148
Ligand excluded by PLIPSO4.63: 3 residues within 4Å:- Chain K: P.161, S.162, S.163
Ligand excluded by PLIPSO4.67: 5 residues within 4Å:- Chain L: K.50, S.163, T.164, G.165
- Ligands: FEC.64
Ligand excluded by PLIPSO4.68: 2 residues within 4Å:- Chain L: N.4, R.5
Ligand excluded by PLIPSO4.69: 3 residues within 4Å:- Chain L: P.161, S.162, S.163
Ligand excluded by PLIPSO4.72: 4 residues within 4Å:- Chain M: K.50, S.163, T.164, G.165
Ligand excluded by PLIPSO4.73: 3 residues within 4Å:- Chain M: S.144, K.147, N.148
Ligand excluded by PLIPSO4.74: 3 residues within 4Å:- Chain M: P.161, S.162, S.163
Ligand excluded by PLIPSO4.77: 6 residues within 4Å:- Chain N: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.81
Ligand excluded by PLIPSO4.78: 2 residues within 4Å:- Chain N: N.4, R.5
Ligand excluded by PLIPSO4.79: 5 residues within 4Å:- Chain F: K.114
- Chain N: K.114
- Chain V: K.114
- Ligands: SO4.33, SO4.125
Ligand excluded by PLIPSO4.80: 3 residues within 4Å:- Chain N: P.161, S.162, S.163
Ligand excluded by PLIPSO4.84: 2 residues within 4Å:- Chain O: S.144, N.148
Ligand excluded by PLIPSO4.85: 3 residues within 4Å:- Chain O: P.161, S.162, S.163
Ligand excluded by PLIPSO4.86: 3 residues within 4Å:- Chain L: K.114
- Chain M: K.114
- Chain P: K.114
Ligand excluded by PLIPSO4.89: 5 residues within 4Å:- Chain P: K.50, S.163, T.164, G.165
- Ligands: FEC.92
Ligand excluded by PLIPSO4.90: 3 residues within 4Å:- Chain P: S.144, K.147, N.148
Ligand excluded by PLIPSO4.91: 3 residues within 4Å:- Chain P: P.161, S.162, S.163
Ligand excluded by PLIPSO4.95: 5 residues within 4Å:- Chain Q: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.96: 2 residues within 4Å:- Chain Q: S.144, N.148
Ligand excluded by PLIPSO4.97: 5 residues within 4Å:- Chain A: K.114
- Chain I: K.114
- Chain Q: K.114
- Ligands: SO4.5, SO4.51
Ligand excluded by PLIPSO4.98: 3 residues within 4Å:- Chain Q: P.161, S.162, S.163
Ligand excluded by PLIPSO4.102: 6 residues within 4Å:- Chain R: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.99
Ligand excluded by PLIPSO4.103: 3 residues within 4Å:- Chain R: S.144, K.147, N.148
Ligand excluded by PLIPSO4.104: 3 residues within 4Å:- Chain R: P.161, S.162, S.163
Ligand excluded by PLIPSO4.105: 2 residues within 4Å:- Chain O: K.114
- Chain S: K.114
Ligand excluded by PLIPSO4.108: 3 residues within 4Å:- Chain S: S.144, K.147, N.148
Ligand excluded by PLIPSO4.109: 3 residues within 4Å:- Chain S: P.161, S.162, S.163
Ligand excluded by PLIPSO4.113: 5 residues within 4Å:- Chain T: K.50, S.163, T.164, G.165
- Ligands: FEC.110
Ligand excluded by PLIPSO4.114: 2 residues within 4Å:- Chain T: N.4, R.5
Ligand excluded by PLIPSO4.115: 3 residues within 4Å:- Chain T: P.161, S.162, S.163
Ligand excluded by PLIPSO4.118: 4 residues within 4Å:- Chain U: K.50, S.163, T.164, G.165
Ligand excluded by PLIPSO4.119: 3 residues within 4Å:- Chain U: S.144, K.147, N.148
Ligand excluded by PLIPSO4.120: 3 residues within 4Å:- Chain U: P.161, S.162, S.163
Ligand excluded by PLIPSO4.123: 6 residues within 4Å:- Chain V: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.127
Ligand excluded by PLIPSO4.124: 2 residues within 4Å:- Chain V: N.4, R.5
Ligand excluded by PLIPSO4.125: 5 residues within 4Å:- Chain F: K.114
- Chain N: K.114
- Chain V: K.114
- Ligands: SO4.33, SO4.79
Ligand excluded by PLIPSO4.126: 3 residues within 4Å:- Chain V: P.161, S.162, S.163
Ligand excluded by PLIPSO4.130: 2 residues within 4Å:- Chain W: S.144, N.148
Ligand excluded by PLIPSO4.131: 3 residues within 4Å:- Chain W: P.161, S.162, S.163
Ligand excluded by PLIPSO4.132: 3 residues within 4Å:- Chain T: K.114
- Chain U: K.114
- Chain X: K.114
Ligand excluded by PLIPSO4.135: 5 residues within 4Å:- Chain X: K.50, S.163, T.164, G.165
- Ligands: FEC.138
Ligand excluded by PLIPSO4.136: 3 residues within 4Å:- Chain X: S.144, K.147, N.148
Ligand excluded by PLIPSO4.137: 3 residues within 4Å:- Chain X: P.161, S.162, S.163
Ligand excluded by PLIP- 12 x FEC: 1,3,5,8-TETRAMETHYL-PORPHINE-2,4,6,7-TETRAPROPIONIC ACID FERROUS COMPLEX(Non-covalent)
FEC.7: 22 residues within 4Å:- Chain A: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, R.58, E.61
- Chain B: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168, K.169
- Ligands: SO4.10
17 PLIP interactions:10 interactions with chain A, 7 interactions with chain B,- Hydrophobic interactions: A:L.24, A:I.27, A:M.31, A:R.58,
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-24-mer
- Ligands
- 48 x FE2: FE (II) ION(Non-covalent)
- 78 x SO4: SULFATE ION(Non-functional Binders)
- 12 x FEC: 1,3,5,8-TETRAMETHYL-PORPHINE-2,4,6,7-TETRAPROPIONIC ACID FERROUS COMPLEX(Non-covalent)